home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Estimate of Relative Mutation Rate has Implications for Medical Genetics

  August, 14 2000 5:33
your information resource in human molecular genetics

In 1947, the biologist J. B. S. Haldane suggested that the rate of genetic mutation is much higher in the male than in the female germ line. This idea has received support from studies in primates generally indicating that mutations occur five times as often in the male than in the female germline.

This ratio is revised sharply downwards - to around 1.7 - in a report in Nature [Vol. 406, Issue 6796 (2000), pp. 622-625] from David C. Page and colleagues from the Howard Hughes Medical Institute at the Whitehead Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts.

This finding has implications for medical genetics, in particular the analysis of sex-linked genetic disorders that are inherited more from the father than the mother.

The researchers' estimate of the relative mutation rate is unprecedentedly accurate, as it is based on a comparison between very large regions of the X and Y chromosomes that contain few genes. So this estimate is unlikely to have been biased by natural selection. In an added twist, the regions compared are around 99% identical: the region on the Y chromosome is a version of part of the X chromosome that was copied and transposed three or four million years ago, early in human evolution. This X-to-Y translocation is not found in chimpanzees or gorillas. This finding allows the rate of subsequent sequence divergence to be calibrated with reference to a known event in humanity's past.


David C. Page tel +1 617 258 5203,
fax +1 617 258 5578, e-mail dcpage@wi.mit.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.